Top

Published in:

01-04-2012

Immunological diseases of the pancreatico-hepatobiliary system: update on etiopathogenesis and cross-sectional imaging findings

Authors: Deepak Garg, Arpit Nagar, Shaile Philips, Naoki Takahashi, Srinivasa R. Prasad, Alampady K. Shanbhogue, Dushyant V. Sahani

Published in: Abdominal Radiology | Issue 2/2012

Abstract

Immunological diseases of the hepatobiliary system and the pancreas include a broad spectrum of disorders that manifest characteristic histopathology/serology and variable clinical features and imaging findings. Recent studies have thrown fresh light on the complex role of genetics and autoimmunity in the pathogenesis and natural history of these diverse disorders that include autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, IgG4-related cholangitis, overlap/outlier syndromes, and autoimmune pancreatitis.

Alpini G, Roberts S, Kuntz SM, et al. (1996) Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology 110:1636–1643PubMedCrossRef

Hirschfield G, Heathcote J, Gershwin M (2010) Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology 139:1481–1496PubMedCrossRef

Manns MP, Strassburg CP (2001) Autoimmune hepatitis: clinical challenges. Gastroenterology 120:1502–1517PubMedCrossRef

Belle SH, Beringer KC, Detre KM (1995) An update on liver transplantation in the United States: recipient characteristics and outcome. Clin Transpl 19–33

Boberg KM, Aadland E, Jahnsen J, et al. (1998) Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 33:99–103PubMedCrossRef

Longhi MS, Ma Y, Mieli-Vergani G, Vergani D (2010) Aetiopathogenesis of autoimmune hepatitis. J Autoimmun 34:7–14PubMedCrossRef

Manns MP, Czaja AJ, et al. (2010) Diagnosis and management of autoimmune hepatitis. Hepatology 51(6):2193–2213PubMedCrossRef

Czaja AJ (2005) Current concepts in autoimmune hepatitis. Ann Hepatol 4:6–24PubMed

Czaja AJ, Manns MP (2010) Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 139(1):58–72PubMedCrossRef

10.

Sahni VA, Raghunathan G, Mearadji B, et al. (2010) Autoimmune hepatitis: CT and MR imaging features with histopathological correlation. Abdom Imaging 35:75–84PubMedCrossRef

11.

Bilaj F, Hyslop WB, Rivero H, et al. (2005) MR imaging findings in autoimmune hepatitis: correlation with clinical staging. Radiology 236:896–902PubMedCrossRef

12.

Park SZ, Nagorney DM, Czaja AJ (2000) Hepatocellular carcinoma in autoimmune hepatitis. Dig Dis Sci 45:1944–1948PubMedCrossRef

13.

Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C (2011) The development of hepatocellular carcinoma in autoimmune hepatitis patients. A case series. Dig Dis Sci 56(2):276–278CrossRef

14.

Sanchez-Urdazpal L, Czaja AJ, van Hoek B, Krom RA, Wiesner RH (1992) Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology 15:215–221PubMedCrossRef

15.

Crosignani A, Battezzati PM, Invernizzi P, et al. (2008) Clinical features and management of primary biliary cirrhosis. World J Gastroenterol 14:3313–3327PubMedCrossRef

16.

Lleo A, Shimoda S, Ishibashi H, Gershwin ME (2011) Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes. J Gastroenterol 46(1):29–38PubMedCrossRef

17.

Bogdanos DP, Mieli-Vergani G, Vergani D (2009) Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis 29:241–253PubMedCrossRef

18.

Lindor KD, Gershwin ME, Poupon R, et al. (2009) Primary biliary cirrhosis. Hepatology 50:291–308PubMedCrossRef

19.

Hirschfield GM, Liu X, Xu C, et al. (2009) Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 360:2544–2555PubMedCrossRef

20.

Jones DE (2007) Pathogenesis of primary biliary cirrhosis. Gut 56:1615–1624PubMed

21.

Kumagi T, Heathcote EJ (2008) Primary biliary cirrhosis. Orphanet J Rare Dis 3:1PubMedCrossRef

22.

Kobayashi S, Matsui O, Gabata T, et al. (2005) MRI findings of primary biliary cirrhosis: correlation with Scheuer histologic staging. Abdom Imaging 30:71–76PubMedCrossRef

23.

Wenzel JS, Donohoe A, Ford KL III, et al. (2001) Primary biliary cirrhosis: MR imaging findings and description of MR imaging periportal halo sign. AJR Am J Roentgenol 176:885–889PubMed

24.

Blachar A, Federle MP, Brancatelli G (2001) Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients. Radiology 220:329–336PubMed

25.

Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127:S35–S50PubMedCrossRef

26.

Washington MK (2007) Autoimmune liver disease: overlap and outliers. Mod Pathol 20(Suppl 1):S15–S30PubMedCrossRef

27.

Chapman R, Fevery J, Kalloo A, et al. (2010) Diagnosis and management of primary sclerosing cholangitis. Hepatology 51:660–678PubMedCrossRef

28.

Mendes F, Lindor KD (2010) Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol 7(11):611–619PubMed

29.

Aron JH, Bowlus CL (2009) The immunobiology of primary sclerosing cholangitis. Semin Immunopathol 31:383–397PubMedCrossRef

30.

Juran BD, Lazaridis KN (2006) Genetics of hepatobiliary diseases. Clin Gastroenterol Hepatol 4:548–557PubMedCrossRef

31.

Karlsen T, Schrumpf E, Boberg KM (2010) Primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 24(5):655–666PubMedCrossRef

32.

Silveira MG, Lindor KD (2008) Primary sclerosing cholangitis. Can J Gastroenterol 22:689–698PubMed

33.

Broome U, Glaumann H, Hellers G, et al. (1994) Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm. Gut 35:84–89PubMedCrossRef

34.

Pokorny CS, McCaughan GW, Gallagher ND, Selby WS (1992) Sclerosing cholangitis and biliary tract calculi—primary or secondary? Gut 33:1376–1380PubMedCrossRef

35.

LaRusso NF, Shneider BL, Black D, et al. (2006) Primary sclerosing cholangitis: summary of a workshop. Hepatology 44:746–764PubMedCrossRef

36.

Beuers U, Rust C (2005) Overlap syndromes. Semin Liver Dis 25:311–320PubMedCrossRef

37.

Ben-Ari Z, Czaja AJ (2001) Autoimmune hepatitis and its variant syndromes. Gut 49:589–594PubMedCrossRef

38.

Hyslop WB, Kierans AS, Leonardou P, et al. (2010) Overlap syndrome of autoimmune chronic liver diseases: MRI findings. J Magn Reson Imaging 31:383–389PubMedCrossRef

39.

Yoshida K, Toki F, Takeuchi T, et al. (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568PubMedCrossRef

40.

Takahashi N, Kawashima A, Fletcher JG, Chari ST (2007) Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 242:791–801PubMedCrossRef

41.

Sato Y, Notohara K, Kojima M, et al. (2010) IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int 60:247–258PubMedCrossRef

42.

Okazaki K, Uchida K, Miyoshi H, et al. (2010) Recent concepts of autoimmune pancreatitis and IgG4-related disease. Clin Rev Allergy Immunol. doi:10.1007/S12016-010-8214-2

43.

Takuma K, Kamisawaa T, Igarashi Y (2011) Autoimmune pancreatitis and IgG4-related sclerosing cholangitis. Curr Opin Rheumatol 23:80–87PubMedCrossRef

44.

Pezzilli R, Labate A (2010) The concept of autoimmune pancreatitis and its immunological background. Expert Rev Clin Immunol 6(1):125–136PubMedCrossRef

45.

Manfredi R, Graziani R, Cicero C, et al. (2008) Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology 247:435–443PubMedCrossRef

46.

Sah RP, Chari ST, Pannala R, et al. (2010) Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 139(1):140–148 (quiz e112–e143)PubMedCrossRef

47.

Bodily K, Takahashi N, Fletcher J, et al. (2009) Autoimmune pancreatitis: pancreatic and extrapancreatic imaging findings. AJR Am J Roentgenol 192:431–437PubMedCrossRef

48.

Gerstenmaier JF, Malone DE (2010) Mass lesions in chronic pancreatitis: benign or malignant? An “evidence-based practice approach”. Abdom Imaging. doi:10.1007/s00261-010-9658-9

49.

Yang DH, Kim KW, Kim TK, et al. (2006) Autoimmune pancreatitis: radiologic findings in 20 patients. Abdom Imaging 31:94–102PubMedCrossRef

50.

Sahani DV, Sainani NI, Deshpande V, et al. (2009) Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy. Radiology 250:118–129PubMedCrossRef

51.

Law R, Bronner M, Vogt D, Stevens T (2009) Autoimmune pancreatitis: a mimic of pancreatic cancer. Clevel Clin J Med 76:607–615CrossRef

52.

Kim H, Chung M, Chung J (2010) Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment. Pancreas 39(5):555–560PubMedCrossRef

53.

Kamisawa T, Tsuruta K, Okamoto A, et al. (2009) Frequent and significant K-ras mutation in the pancreas, the bile duct, and the gallbladder in autoimmune pancreatitis. Pancreas 38:890–895PubMedCrossRef

54.

Forcione D, Brugge W (2010) New kid on the block? Autoimmune pancreatitis. Best Pract Res Clin Gastroenterol 24:361–378PubMedCrossRef

Title: Immunological diseases of the pancreatico-hepatobiliary system: update on etiopathogenesis and cross-sectional imaging findings
Authors: Deepak Garg
Arpit Nagar
Shaile Philips
Naoki Takahashi
Srinivasa R. Prasad
Alampady K. Shanbhogue
Dushyant V. Sahani
Publication date: 01-04-2012
Publisher: Springer-Verlag
Published in: Abdominal Radiology / Issue 2/2012
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-011-9759-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2012

Obscure and occult gastrointestinal bleeding: role of radionuclide imaging

Overload hepatitides: quanti-qualitative analysis

New acquisition techniques: fields of application

Microvascular structure and perfusion imaging of colon cancer by means of contrast-enhanced ultrasonography

Hepatocellular carcinoma: MR staging and therapeutic decisions

Cirrhosis and pre-neoplastic lesions

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials